Board of Directors

About

The board of directors at Immunome has a long history of experience in the field of oncology research. The current CEO and Founder, Dr. John V. Oyler, has previously served as the Director of Clinical Research at NEXT Oncology San Antonio, as well as the Director of Clinical Research and Co-Founder at START- South Texas Accelerated Research Therapeutics. In addition, he was the Director of Clinical Research at Institute for Drug Development, and a Fellow at National Cancer Institute. Dr. Oyler is also an Associate Professor at University of Toronto, and has served as the Coordinator for the Graduate Toxicology Group Seminar Series and Director for the Murine Imaging and Histology Core facility, as well as the Antibody / Epitope Recognition Database. Furthermore, he is the Director at Lombardi Comprehensive Cancer Center, Board Member at Hydrofarm, and Managing Member at Broadband Capital Investments, LLC.The other members of the board also have significant experience in their field. For example, Professor and Vice Chair of the Department of Microbiology at University of Pennsylvania David R. Andes has also served as a Postdoctoral fellow at UC San Francisco and as a Member of the Board Of Directors at IGM Biosciences. Additionally, Owner at BiStro Biotech Consulting LLC Bettina M. Davis has over 20 years of experience in the biotech industry and has served as VP and Biologics Fellow, Janssen BioTherapeutics at